MedDataX Logo

Asthma in the Elderly: The Role of Exhaled Nitric Oxide Measurements

NCT ID: NCT00939354

Last Updated: 2015-10-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-07-31

Study Completion Date

2011-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will investigate the importance of exhaled nitric oxide measurements in subjects with asthma age 65 and older. This group of patients has been ignored in most previous asthma studies.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Asthma in the Elderly: The Effect of Montelukast

NCT02635334

Asthma
COMPLETED PHASE4

Investigation of Lung Ventilation Inhomogeneity in Pediatric Asthma

NCT01095354

Asthma
COMPLETED

Symptom Perception

NCT03646669

Asthma
COMPLETED NA

Asthma Symptom Perception Study

NCT06612294

Asthma
RECRUITING NA

Asthma in the Elderly: A Study of Choline Supplementation

NCT02371993

Asthma in the Elderly
COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects with asthma over the age of 65 followed in our practice, non-smokers and able to give informed consent to participate in the study

Exclusion Criteria

* Smokers, subjects of diminished mental capacity
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Michele Columbo, M.D.

Co-Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Albert S Rohr, M.D.

Role: PRINCIPAL_INVESTIGATOR

Rohr and Columbo Associates

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

F/N-R09-2839B

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Environmental Exposures, Genetics, and Exhaled Nitric Oxide in Pediatric Asthma
NCT00395096 COMPLETED
Community Based Study of Adult Onset Asthma
NCT00005544 COMPLETED
Effects of Allergen Inhalation on Adenosine Receptor Expression in Sputum and Peripheral Blood
NCT00116311 UNKNOWN
Immune Dysregulation in Children and Adults With Asthma
NCT00135681 COMPLETED NA
Low Exhaled NO and ICS in Suspected Asthma
NCT02771717 UNKNOWN PHASE4
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
NCT03885245 RECRUITING PHASE2
Daily Monitoring of Exhaled Nitric Oxide in Asthmatic Patients
NCT01113853 COMPLETED
Efficacy of Ciclesonide on Small Airways in Patients With Stable Asthma (18 to 60 y) (BY9010/M1-131)
NCT00163345 COMPLETED PHASE3
Evaluation of an Asthma Treatment Strategy Based on Exhaled Nitric Oxide Measurements in Adolescents
NCT00114413 COMPLETED NA
Asthma Self-Management in Older Adults
NCT00941694 COMPLETED NA
The Effect of Long Term Inhaled Corticosteroids on the Risk of Cardiovascular Morbidities
NCT00959257 COMPLETED
Redox Determinants of Severe Asthma (a Substudy of the Severe Asthma Research Program)
NCT00590005 COMPLETED
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
NCT00576069 RECRUITING
Biomarkers in Exhaled Breath From Asthmatic Patients
NCT00635271 TERMINATED
Some Biomarkers in Bronchial Asthma in Children
NCT04175093 UNKNOWN
Predictive Ability of Therapeutic Risk Factors in Pediatric and Adult Asthma Patients
NCT01346852 COMPLETED
Self Operating of the Personal WheezoMeter by Intended Users - A Usability Study
NCT00901433 COMPLETED
Study in Adult Patients With Moderate to Severe Asthma
NCT04886999 COMPLETED PHASE3
Cell Distribution in Induced Sputum in Patients With Asthma
NCT01543516 COMPLETED
Towards Restoring the Physiological Inhibition of Airway Narrowing in Asthma
NCT00279136 UNKNOWN
NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)
NCT02327897 RECRUITING
Diagnosing Asthma With Clinically Accessible, Non-invasive, and Efficient Tests: a Child-inclusive Translational Investigation
NCT07011394 RECRUITING
Effect of Heredity and Environment on Asthma Development and Severity in Puerto Rican Children
NCT00461227 COMPLETED
Asthma in Pregnancy
NCT05047419 COMPLETED
Electronic Monitoring of Medication Adherence in Moderate to Severe Asthma Patients
NCT02913092 COMPLETED NA